UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT
Huang, Guo, Zhao, Ning, Wang, Gu, Zhang, Qu, Zhang, Song (2020) UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT Aging (Albany NY) (IF: 4.9) 12(11) 10275-10289
Full text
Click the PDF icon to view the full text of the paper
Abstract
Glioblastoma (GBM) generally has a dismal prognosis, and it is associated with a poor quality of life as the disease progresses. However, the development of effective therapies for GBM has been deficient. Ubiquitin-conjugating enzyme E2T (UBE2T) is a member of the E2 family in the ubiquitin-proteasome pathway and a vital regulator of tumour progression, but its role in GBM is unclear. In this study, we aimed to clarify the role of UBE2T in GBM. Bioinformatics analysis identified UBE2T as an independent risk factor for gliomas. Immunohistochemistry was used to measure UBE2T expression in GBM and normal tissue samples obtained from patients with GBM. The effects of UBE2T on GBM cell invasion and migration were analysed using the Transwell assay. BALB/c nude mice were used for the in vivo assays. Immunoblotting and immunoprecipitation were performed to determine the molecular mechanisms. UBE2T was highly expressed in GBM tissues, and its expression was linked to a poor prognosis. In vitro, depletion of UBE2T significantly suppressed cell invasion and migration. Moreover, UBE2T depletion suppressed the growth of GBM subcutaneous tumours in vivo. Further experiments revealed that UBE2T suppressed invasion and migration by regulating epithelial- mesenchymal transition (EMT) via stabilising GRP78 in GBM cells. We uncovered a novel UBE2T/GRP78/EMT regulatory axis that modulates the malignant progression and recurrence of GBM, indicating that the axis might be a valuable therapeutic target.
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346020http://www.ncbi.nlm.nih.gov/pubmed/32491994
http://dx.doi.org/10.18632/aging.103239
